BBWI Stock Down on Soft Q3 Earnings, Transformation Plan Unveiled
Bath & Body Works sinks after a soft third quarter and trimmed 2025 outlook, even as its new Consumer First strategy aims to reignite growth.
Autodesk to Report Q3 Earnings: What's in the Cards for the Stock?
ADSK's Q3 performance is likely to have benefited from AECO strength and recurring revenue gains, while FX pressures and its new transaction model may weigh.
DICK'S Set to Report Q3 Results: What to Watch for This Season?
DKS' Q3 results are expected to reflect improving sales, softer earnings and the impact of strategy, margins and macro pressures.
Is Burlington Stores Set for Another Surprise as Q3 Earnings Approach?
BURL readies its Q3 report as investors watch for another potential beat driven by agile buying and stronger in-store execution.
Kohl's Q3 Earnings Coming Up: Factors Investors Need to Understand
KSS' third-quarter results are likely to reflect soft traffic, pressured consumers and rising cost and pricing headwinds despite steadier proprietary brand trends.
TJX Q3 Earnings and Sales Beat Estimates, Fiscal 2026 Guidance Raised
TJX posts strong third quarter beats, lifts fiscal 2026 guidance as sales, margins and comps rise across every division.
Here's Why Five Below ( FIVE ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BJ's Wholesale Q3 Earnings on Deck: Will BJ Surprise Wall Street?
BJ eyes higher Q3 revenues, but a potential earnings decline keeps Wall Street watching for surprises.
Gap Q3 Earnings Coming Up: What's in Store for the Stock?
GAP's Q3 performance is likely to have benefited from brand momentum and strong back-to-school trends, but rising tariff pressures might have eroded gains.
Is Five Below ( FIVE ) Outperforming Other Retail-Wholesale Stocks This Year?
Here is how Five Below (FIVE) and Kroger (KR) have performed compared to their sector so far this year.
Important Notice to Long-Term Shareholders of Avantor, Inc. ( NYSE: AVTR ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; Maison Solutions Inc. ( NASDAQ: MSS ) ; and Unicycive Therapeutics, Inc. ( NASDAQ: UNCY ) : Grabar Law Office Investigates Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Avantor ( NYSE:AVTR )
PHILADELPHIA , Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. ( NYSE:AVTR ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Is Five Below Inc Gaining or Losing Market Support? - Five Below ( NASDAQ:FIVE )
Five Below Inc's ( NYSE:FIVE ) short interest as a percent of float has fallen 14.33% since its last report. According to exchange reported data, there are now 3.32 million shares sold short, which is 6.16% of all regular shares that are available for trading.
Dollar Tree's Upside Squeezed As Shoppers Seek Better Deals - Dollar Tree ( NASDAQ:DLTR )
Dollar Tree, Inc. ( NASDAQ:DLTR ) is trading lower on Thursday. Doubts are piling up about the retailer's ability to sustain momentum against rivals that appear to be sharpening their pricing and merchandising.
TJX Q3 Earnings Coming Up: Key Factors You Should Understand
The TJX Companies' third-quarter results are likely to reflect sales momentum and customer growth amid pressure from higher wages and tariffs.
Lowe's Q3 Earnings Coming Up: Will LOW Extend Its Beat Streak?
Lowe's Q3 2025 results on Nov. 19 are likely to test its earnings streak as Pro strength, digital upgrades and margin efforts meet housing headwinds.
Sally Beauty Q4 Earnings Beat Estimates, Sales Increase Y/Y
SBH posts a solid fourth quarter as both earnings and sales rise year over year, boosted by margin gains and strong online performance.
Why Five Below ( FIVE ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sally Beauty Gears Up for Q4 Earnings: What to Expect From the Stock?
SBH braces for soft fiscal fourth-quarter results as cost pressures and cautious consumer behavior weigh on sales and margins.
Dillard's Pre-Q3 Earnings Indicate Mixed Trends: Is It Worth Buying?
DDS's Q3 outlook indicates pressure on sales and profits, though store upgrades and e-commerce gains may soften the impacts.
Important Notice to Long-Term Shareholders of Avantor, Inc. ( NYSE: AVTR ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; Molina Healthcare, Inc. ( NYSE: MOH ) ; and Unicycive Therapeutics, Inc. ( NASDAQ: UNCY ) : Grabar Law Office Investigates Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Avantor ( NYSE:AVTR )
PHILADELPHIA, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. ( NYSE:AVTR ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Groupon ( GRPN ) Reports Q3 Loss, Tops Revenue Estimates
Groupon (GRPN) delivered earnings and revenue surprises of -29,300.00% and +0.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Giving Extra This Holiday Season With Big Savings From Five Below - Five Below ( NASDAQ:FIVE )
PHILADELPHIA, PA, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Five Below, Inc. ( NASDAQ:FIVE ) , the trend-right, extreme-value brand for kids is once again decking the aisles of stores nationwide with must-have gifts and décor, making it easy to give extra this holiday season.
Will Five Below ( FIVE ) Beat Estimates Again in Its Next Earnings Report?
Five Below (FIVE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Notice to Long-Term Shareholders of Avantor, Inc. ( NYSE: AVTR ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; Humana Inc. ( NYSE: HUM ) ; and Molina Healthcare, Inc. ( NYSE: MOH ) : Grabar Law Office Investigates Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Avantor ( NYSE:AVTR )
PHILADELPHIA, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. ( NYSE:AVTR ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Why Five Below ( FIVE ) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Best Momentum Stock to Buy for Oct. 30th
GLW, HTBK and FIVE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 30, 2025.
Why Five Below ( FIVE ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Has Five Below ( FIVE ) Outpaced Other Retail-Wholesale Stocks This Year?
Here is how Five Below (FIVE) and Zumiez (ZUMZ) have performed compared to their sector so far this year.
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; Humana Inc. ( NYSE: HUM ) ; and Treace Medical Concepts ( NASDAQ: TMCI ) : Grabar Law Office Investigates Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Amylyx Pharmaceuticals ( NASDAQ:AMLX )
PHILADELPHIA, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) as securities fraud class action ...
New Strong Buy Stocks for Oct. 30: HTBK, HCA, and More
HTBK, HCA, FUTU, FIVE and EBMT have been added to the Zacks Rank #1 (Strong Buy) List on October 30, 2025.
Important Notice to Long-Term Shareholders of Five Below, Inc. ( NASDAQ: FIVE ) ; Humana Inc. ( NYSE: HUM ) ; Treace Medical Concepts ( NASDAQ: TMCI ) ; and Unicycive Therapeutics, Inc. ( NASDAQ: UNCY ) : Grabar Law Office Investigates Claims on Your Behalf - Humana ( NYSE:HUM ) , Five Below ( NASDAQ:FIVE )
PHILADELPHIA, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Five Below Inc. ( NASDAQ:FIVE ) as securities fraud class action complaint allegations have survived a motion to dismiss.
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Five Below ( NASDAQ:FIVE ) , Booking Holdings ( NASDAQ:BKNG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Important Notice to Long-Term Shareholders of CS Disco Inc. ( NYSE: LAW ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; Humana Inc. ( NYSE: HUM ) ; and Unicycive Therapeutics, Inc. ( NASDAQ: UNCY ) : Grabar Law Office Investigates Claims on Your Behalf - Humana ( NYSE:HUM ) , Five Below ( NASDAQ:FIVE )
PHILADELPHIA, Oct. 24, 2025 ( GLOBE NEWSWIRE ) -- CS Disco Inc. ( NYSE:LAW ) - Securities Fraud Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of CS Disco Inc. ( NYSE:LAW ) as securities fraud class action complaint ...
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Baxter International Inc. ( NYSE: BAX ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Humana Inc. ( NYSE: HUM ) : Grabar Law Office Investigates Claims on Your Behalf - Amylyx Pharmaceuticals ( NASDAQ:AMLX ) , Baxter Intl ( NYSE:BAX )
PHILADELPHIA, Oct. 23, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) as securities fraud class action ...
Important Notice to Long-Term Shareholders of Baxter International Inc. ( NYSE: BAX ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Humana Inc. ( NYSE: HUM ) ; and Ibotta, Inc. ( NYSE: IBTA ) : Grabar Law Office is Investigating Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Baxter Intl ( NYSE:BAX )
PHILADELPHIA, Oct. 21, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. ( NYSE:BAX ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Five Below, Inc. ( FIVE ) Soars to 52-Week High, Time to Cash Out?
Five Below (FIVE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tariffs Test Tractor Supply's Margins: Can Rural Strength Hold Up?
TSCO posts record sales and margin gains but warns that tariffs may test its profitability as cost pressures rise in 2025.
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Baxter International Inc. ( NYSE: BAX ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Humana Inc. ( NYSE: HUM ) : Grabar Law Office is Investigating Claims on Your Behalf - Amylyx Pharmaceuticals ( NASDAQ:AMLX ) , Baxter Intl ( NYSE:BAX )
PHILADELPHIA, Oct. 20, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) as securities fraud class action ...
The Best Small-Cap Stock ETF to Invest $100 in Right Now Is the Avantis U.S. Small Cap Value ETF ( AVUV )
This ETF has outpaced the S&P 500 over the past five years.
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Humana Inc. ( NYSE: HUM ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Hertz Global Holdings, Inc. ( NASDAQ: HTZ ) : Grabar Law Office is Investigating Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Amylyx Pharmaceuticals ( NASDAQ:AMLX )
PHILADELPHIA, Oct. 17, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss:
Five Below Makes Its Pacific Northwest Debut, Bringing Extreme Value to the Region With Eight New Stores
With new stores across Washington and Oregon opening in November, locals and visitors across the region can enjoy shopping Five Below's extensive assortment of trend-right finds, brands kids love and everyday unbeatable deals With new stores across Washington and Oregon opening in November, ...
Five Below Makes Its Pacific Northwest Debut, Bringing Extreme Value to the Region With Eight New Stores - Five Below ( NASDAQ:FIVE )
PHILADELPHIA, PA, Oct. 17, 2025 ( GLOBE NEWSWIRE ) -- Five Below, Inc. ( NASDAQ:FIVE ) , the trend-right, extreme-value brand for kids today announced it will bring its one-of-a-kind shopping experience to the Pacific Northwest for the very first time this November.
Important Notice to Long-Term Shareholders of Altimmune, Inc. ( NASDAQ: ALT ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; Flywire Corporation ( NASDAQ: FLYW ) ; and Hertz Global Holdings, Inc. ( NASDAQ: HTZ ) : Grabar Law Office is Investigating Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Altimmune ( NASDAQ:ALT )
PHILADELPHIA, Oct. 16, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Altimmune, Inc. ( NASDAQ:ALT ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Humana Inc. ( NYSE: HUM ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Treace Medical Concepts, Inc. ( NASDAQ: TMCI ) : Grabar Law Office is Investigating Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Amylyx Pharmaceuticals ( NASDAQ:AMLX )
PHILADELPHIA , Oct. 13, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss:
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Humana Inc. ( NYSE: HUM ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Vestis Corp. ( NYSE: VSTS ) : Grabar Law Office is Investigating Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Amylyx Pharmaceuticals ( NASDAQ:AMLX )
PHILADELPHIA, Oct. 09, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) as securities fraud class action ...
Five Below Appoints Chief Financial Officer and Chief Merchandising Officer - Five Below ( NASDAQ:FIVE )
PHILADELPHIA, PA, Oct. 01, 2025 ( GLOBE NEWSWIRE ) -- Five Below, Inc. ( NASDAQ:FIVE ) ( "Five Below" or "the Company" ) , the trend-right, high-quality, extreme-value retailer for the kid and the kid in all of us, today announced the appointments of Daniel Sullivan as Chief Financial Officer ( ...
Five Below Appoints Chief Financial Officer and Chief Merchandising Officer
Extreme-value growth retailer names Daniel Sullivan as Chief Financial Officer and Michelle Israel as Chief Merchandising Officer, rounding out its executive leadership team Extreme-value growth retailer names Daniel Sullivan as Chief Financial Officer and Michelle Israel as Chief Merchandising ...
Five Below ( FIVE ) Up 1.1% Since Last Earnings Report: Can It Continue?
Five Below (FIVE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Costco Q4 Preview: Analyst Calls Retailer 'A Share Gainer' Thanks To Value And Member Loyalty - Costco Wholesale ( NASDAQ:COST )
Costco Wholesale Corporation COST could offer insight at the health of consumer spending when the retailer reports fourth-quarter financial results Thursday after market close. Here are the earnings estimates, what analysts are saying ahead of the report, and key items to watch.
Here's How Strong Q2 Results & Store Growth Lift FIVE's FY25 Outlook
Five Below raises its FY25 outlook, now expecting stronger sales, margins and EPS after a robust Q2 performance.
